Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006528

Chief Commercial Officer acquired 170,188 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Habig Scott Michael Chief Commercial Officer 2023-03-02 Grant or award +170,188 312,719 D
Loading xslF345X03/wf-form4_167813810165437.xml…